Drug Research

A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an appealing market for investment. AstraZeneca defies geopolitics to bet on China – Financial Times (paywalled) AstraZeneca's CEO...

As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is expected to CAGR (experience a compound annual growth rate) of 8.4 percent between 2023 and...

The Biden administration has issued new guidelines for its program that enables Medicare to directly negotiate drug prices with manufacturers. The updated guidelines provide clarity on how the Centers for Medicare & Medicaid Services (CMS) will identify the drugs...

NICA, PhRMA, and GCCA lodged a complaint in the U.S. District Court for the Western District of Texas, asserting that the price setting provisions outlined in the Inflation Reduction Act infringe upon the Constitution. They argue that these provisions...

On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came to the new powers of Medicare to cut medicine prices for seniors as per the...

In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from emerging markets like China as well as the US when one talks of innovation and...

SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. SK pharmteco...